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Toxicity of Familial ALS-Linked SOD1 Mutants
from Selective Recruitment to Spinal Mitochondria
mitochondria as the basis for their selective toxicity
in ALS.
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Umea˚ University Hospital et al., 1995; Wang et al., 2002, 2003), and rats (Nagai et
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S 901 87 Umea˚ voke selective, age-dependent killing of motor neurons
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SOD1 is a homodimer, and for its dismutase activity
each subunit binds a copper atom at the catalytic site.Summary
The ALS-linked SOD1 mutations retain highly varied bio-
chemical properties including levels of dismutase activ-One cause of amyotrophic lateral sclerosis (ALS) is
ity, binding of the catalytic copper, and subunit half-lifemutation in ubiquitously expressed copper/zinc su-
(Borchelt et al., 1994; Ratovitski et al., 1999; Haywardperoxide dismutase (SOD1), but the mechanism of tox-
et al., 2002; Rodriguez et al., 2002; Tiwari et al., 2002).icity to motor neurons is unknown. Multiple disease-
Acquisition of most copper by SOD1 is facilitated by acausing mutants, but not wild-type SOD1, are now
Copper Chaperone for SOD1 (CCS) (Culotta et al., 1997),demonstrated to be recruited to mitochondria, but only
a member of the family of metallochaperones that arein affected tissues. This is independent of the copper
responsible for intracellular trafficking of metal ionschaperone for SOD1 and dismutase activity. Highly
(O’Halloran and Culotta, 2000). Disruption of the CCSpreferential association with spinal cord mitochondria
gene in each of the three most frequently used ALSis seen in human ALS for a mutant SOD1 that accumu-
mouse models has shown that disease is unaffected bylates only to trace cytoplasmic levels. Despite variable
elimination of CCS-mediated copper loading (Subra-proportions that are successfully imported, nearly
maniam et al., 2002). This finding, and the absence ofconstant amounts of SOD1 mutants and covalently
detectable copper loading onto SOD1 after injection ofdamaged adducts of them accumulate as apparent
radiolabeled copper into CCS-deleted, mutant SOD1-import intermediates and/or are tightly aggregated or
expressing mice (Subramaniam et al., 2002), have beencrosslinked onto integral membrane components on
interpreted (Orr, 2002) to weigh against proposals (Beck-the cytoplasmic face of those mitochondria. These
man et al., 1993; Estevez et al., 1999) that the primaryfindings implicate damage from action of spinal cord-
toxicity arises from aberrant, copper-mediated oxidativespecific factors that recruit mutant SOD1 to spinal
chemistry by the mutant enzymes. This is complicated,
however, by an apparent 20% residual dismutase ac-
tivity measured in vitro in samples from CCS-depleted*Correspondence: dcleveland@ucsd.edu
animals (Subramaniam et al., 2002).7Present address: California Pacific Medical Center, 2330 Clay
Street, San Francisco, California 94115. Although the selectivity of motor neuron killing pro-
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duced by the many ALS-linked mutants implies that they mitochondria and demonstrating that little, if any, mouse
SOD1WT associates with spinal cord mitochondria evenshare one (or more) disease-provoking toxic properties,
in the presence of a high concentration of the disease-the mechanism(s) of such toxicity remains elusive. Mito-
causing SOD1G37R mutant. In contrast, although it retainschondrial abnormalities within motor neurons were ob-
full specific activity as a superoxide dismutase and effi-served as one of the early pathological features in both
ciently heterodimerizes with mSOD1WT (Wong et al.,SOD1G93A and SOD1G37R mice (Dal Canto and Gurney,
1995; Borchelt et al., 1994), a proportion of the SOD1G37R1994; Wong et al., 1995; Kong and Xu, 1998), although
mutant, in the absence of detectable endogenoussimilar pathology has not been found in other transgenic
mSOD1WT, also remained associated with purified mito-lines that develop ALS-like disease from expressing
chondria (Figure 1B, lane 4).mutants SOD1G85R (Bruijn et al., 1997; Ripps et al., 1995)
This mitochondrial association was a general propertyor SOD1H46R/H48Q (Wang et al., 2002). A 25% decrement
of ALS-linked SOD1 mutants with very different bio-in mitochondrial function has been reported in SOD1G93A
chemical characteristics, as seen in spinal cord mito-mice that accumulate an enzymatically active SOD1 mu-
chondria prepared from lines that develop motor neurontant to 10 times the endogenous mouse SOD1
disease from expression of three additional ALS-linked(mSOD1WT) level, albeit this was neither seen before dis-
SOD1 mutants. These included mice expressing (1) mu-ease onset nor selective to mitochondria from spinal
tant SOD1G93A that retains significant activity as a dismu-cord (Mattiazzi et al., 2002). Mutant SOD1G93A has also
tase (Gurney et al., 1994; Howland et al., 2002), but whichbeen detected within spinal cord mitochondria using
may also catalyze aberrant oxidative chemistry (Wiedau-electron microscopy (Jaarsma et al., 2001; Higgins et
Pazos et al., 1996; Andrus et al., 1998), (2) mutantal., 2002) and in intact mitochondria from brain by its
SOD1G85R that retains little, if any, dismutase activityapparent resistance to protease digestion (Mattiazzi et
(Corson et al., 1998), and (3) mutant SOD1H46R/H48Q thatal., 2002).
carries two ALS-linked mutations that eliminate dismu-As to the mechanism underlying selective killing of
tase activity through loss of two of the four catalyticmotor neurons in ALS, we now identify preferential accu-
copper-coordinating histidines (Wang et al., 2002). Un-mulation of mutant SOD1s with mitochondria to be: (1)
like SOD1G37R and SOD1G93A, both inactive mutants alsocommon to a series of ALS-linked SOD1 mutants includ-
fail to form stable heterodimers with the wild-type SOD1ing one mutant that accumulates only to trace levels in
(Bruijn et al., 1997; Wang et al., 2002).the cytoplasm in human disease, (2) selective for spinal
Mitochondria were isolated from spinal cords fromcord mitochondria, (3) independent of dismutase activity
symptomatic mice expressing each of the four ALS-and CCS, (4) accompanied by covalent damage to mito-
linked SOD1 mutants, as well as from nontransgenicchondrial bound proteins, including mutant SOD1s, and
mice or aged mice expressing a high level of human(5) mediated by very tight association and/or crosslink-
wild-type SOD1 (hSOD1WT) that never develop motoring to integral membrane proteins of the outer mitochon-
neuron disease. All four mutant SOD1s (Figure 2A, lanesdrial membrane. These findings implicate damage from
4, 6, 8, and 10) were present in the spinal cord mitochon-action of spinal cord-specific factors that recruit mutant
drial fractions. In contrast, despite chronic expressionSOD1 to spinal mitochondria as the basis for their selec-
of high levels of hSOD1WT, none was detected with mito-tive toxicity in ALS.
chondria (Figure 2A, lane 12). Similarly, mSOD1WT was also
below detectable levels (except after very long expo-
Results sures; quantified in Table 1) in these purified mitochon-
dria, despite its known efficient heterodimerization in
Disease-Inducing Mutant SOD1s, but not Wild-Type the cytoplasm with the SOD1G37R and SOD1G93A mutants.
SOD1, Associate with Spinal Cord Mitochondria The preferential association of mutant SOD1 with spi-
Mitochondria were isolated by differential sedimentation nal cord mitochondria was most striking for SOD1G85R
of central nervous tissue extracts from both nontrans- (Figure 2A, lanes 5 versus 6; Table 1), the mutant that
genic and symptomatic mice expressing ALS-linked accumulates to the lowest level and does not exhibit
SOD1G37R mutant, followed by further purification through detectable dismutase activity. Furthermore, despite
a density gradient (Figure 1A). Immunoblotting of equal strikingly different cytoplasmic levels of the various SOD1
proportions of aliquots from each step revealed a nearly mutants (Figure 2A, lanes 3, 5, 7, 9) (and levels required
quantitative recovery of mitochondria in the final purified to cause disease [Bruijn et al., 1997]), these four ALS-
fraction, as judged by retention of inner membrane and linked SOD1 mutants accumulated to levels that differed
matrix markers (COX4 and Hsp60, respectively) (Figure by no more than 2-fold in the mitochondrial fractions
1B, lanes 1–4), while nonmitochondrial membranous or- (e.g., compare signal intensities in Figure 2A, lanes 4,
ganelles were essentially eliminated, as seen by ab- 6, 8, and 10 using an antibody that recognizes each
sence of syntaxin 6 and synaptotagmin (Figure 1B, lane mutant with equal affinity; Table 1).
4). Moreover, relative to other mitochondrial markers, Accumulation of mutant SOD1 with mitochondria was
the retention of a high level of cytochrome c, a compo- selective for affected tissues. Despite overall accumula-
nent in the mitochondrial intermembrane space (IMS), tion to levels comparable to that seen in spinal cords,
indicated that mitochondria remained structurally intact neither the mutant SOD1s nor hSOD1WT was associated
during purification (Figure 1B, lane 4). Despite its high with mitochondria from skeletal muscle (compare Figure
abundance in the initial extracts, the endogenous 2B, lanes 4, 6, 8, and 10). Despite showing the highest
mSOD1WT was almost quantitatively removed during mi- proportion associated with spinal cord mitochondria, no
tochondrial purification, confirming the absence of sig- SOD1G85R was detectable in purified mitochondria from
whole brain or liver (Figure 2C, lanes 8 and 10). Con-nificant cytoplasmic contamination in the final purified
Mutant SOD1 Associated with Spinal Mitochondria
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Figure 1. Isolation of Highly Purified Mitochondria
(A) Schematic of mitochondrial purification.
(B) Immunoblotting of equal proportions of each fraction from the purification. Mitochondrial markers COX4, cytochrome c, and Hsp60 were
used to assess the recovery of mitochondrial fractions from nontransgenic or symptomatic SOD1G37R transgenic mice, while immunoblotting
for syntaxin 6 and synaptotagmin were used to assess the removal of other membranous components.
versely, although almost entirely absent from spinal cord Mutant SOD1 in Mitochondria Is Independent
of CCS and Dismutase Activitymitochondria (Figure 2C, lanes 2 and 4), an easily detect-
By disruption in mice of the gene encoding CCS, mutantable proportion of mSOD1WT was associated with liver
toxicity from SOD1G93A, SOD1G37R, and SOD1G85R mice hasmitochondria (Figure 2C, lane 8), while mutant SOD1G85R
been shown to be independent of CCS (Subramaniamwas almost completely excluded (quantified in Table 1).
et al., 2002). Spinal cord mitochondria from symptomatic
SOD1G37R mice with or without a functional CCS gene,
as well as littermate nontransgenic controls, were gener-Mutant SOD1 Association with Spinal Mitochondria
ated. Unlike yeast where SOD1 import into the mito-Is not an Intrinsic Property of Motor Neurons,
chondrial IMS is known to be mediated by CCS (Sturtzbut Is Acquired with Age
et al., 2001), the same level of SOD1G37R was associatedMitochondrial vacuolation has been documented to ap-
with mitochondria regardless of whether or not CCS waspear selectively within a few motor neurons at early ages
present (Figure 3A, lanes 2 and 4). Despite the constant(Dal Canto and Gurney, 1994; Wong et al., 1995; Kong
association of SOD1G37R with mitochondria, overall cyto-and Xu, 1998) of some mice that later develop SOD1
plasmic dismutase activity in the absence of CCS wasmutant-mediated disease. To test whether association
reduced to about 15%–20% of that in the presence ofof mutant SOD1 with these mitochondria reflects an
CCS (Figure 3A, lanes 5 and 6), as previously reportedintrinsic property of motor neurons, mitochondria were
(Subramaniam et al., 2002), indicating that mitochondrialisolated from mice that express mutant SOD1G85R solely
association is also independent of overall dismutasein neurons (Lino et al., 2002). These mice do not develop
activity. Dismutase activity of SOD1G37R associated withdisease or pathology, with SOD1G85R accumulating to
CCS-deficient mitochondria was reduced modestly com-
5% the level of endogenous mSOD1WT (Figure 2D, lane
pared with similar preparations from CCS-containing
1). Although easily detectable in the cytoplasm using
mice (Figure 3A, lane 7 versus 8), implying CCS-indepen-
antibodies specific for human SOD1 (Figure 2D, lane dent copper loading. Manganese SOD activity was un-
3), none of this neuronal SOD1G85R was associated with changed.
spinal cord mitochondria (Figure 2D, lane 4). Similarly, Most mutant SOD1 mouse models do not produce
when expressed ubiquitously, SOD1G85R did not associ- pathology in the brain (Wong et al., 1995; Bruijn et al.,
ate with spinal cord mitochondria by 5 weeks of age 1997; Wang et al., 2002), and no SOD1G85R is associated
(Figure 2E, lane 2). However, a proportion was associ- with the corresponding brain mitochondria (Figure 2C).
ated in 6-month-old, asymptomatic mice, with the However, as initially reported (Wang et al., 1995),
amount escalating by more than 2-fold after disease SOD1G37R (line 42) is the SOD1G37R line with the highest
onset (Figure 2C, lanes 2 and 4; Table 1). This age- level of mutant expression and earliest disease onset,
dependent accumulation with spinal cord mitochondria and it develops pathology in the brain in addition to the
was selective for mutant SOD1: no mitochondrial spinal cord. We took advantage of this to determine in
hSOD1WT or mSOD1WT was detected even in aged mice this line that not only was mutant SOD1G37R associated
with brain mitochondria, but also that the absence of(Figure 2A, lane 12).
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Figure 2. Selective Association of ALS-Linked Mutant SOD1s with Mitochondria of Affected Tissues
Mutant and wild-type SOD1 content in purified mitochondria (mito) and cytosolic (cyto) fractions were analyzed by immunoblotting samples
from spinal cord (A, D, and E), hind limb skeletal muscle (B), or various tissues from SOD1 mutant, hSOD1WT, or nontransgenic (non-Tg) mice
(C), as indicated. Specific transgenic lines used in (A) and (B) included hSOD1WT (line 76), SOD1G37R (line 42), SOD1G85R (line 148), SOD1G93A (G1H
line), and SOD1H46R/H48Q (line 139). Shown in (D) are Thy1-SOD1G85R mice, and in (E) SOD1G85R mice (line 164).
Table 1. Wild-Type and Mutant SOD1 Associated with Mitochondria
SOD1 Tissues Relative Accumulateda [SOD1]/[COX4]b
hSOD1WT (17.5 mo) spinal cord 8 0.7
hSOD1G37R spinal cord 10 21
hSOD1H46R/H48Q spinal cord 3.5 17
hSOD1G93A spinal cord 7 21
hSOD1G85R (presymptomatic) spinal cord 0.5 6
hSOD1G85R spinal cord 1 13
hSOD1G85R skeletal muscle 0.5 0.01c
hSOD1G85R liver 0.3 0.2
mSOD1WT liver 3 9
a The relative level of mutant or wild-type SOD1 to the level of endogenous mouse SOD1 in spinal cord cytosolic fraction, determined by
immunoblotting. All SOD1 mutant mice were taken after clinical disease onset, except as noted.
b The relative level of SOD1s and COX4 in mitochondrial fractions determined by immunoblotting. Values are normalized to 1.0 for the mSOD1WT/
COX4 ratio in spinal cord fractions from 1-year-old normal mice.
c Undetectable even after very long exposures.
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Figure 3. Association of Mutant SOD1s with Mitochondria Is Independent of CCS and Dismutase Activity
(A and B) Cytosolic and purified mitochondrial fractions from spinal cords (A) and brains (B) of symptomatic SOD1G37R (line 42) transgenic
mice with and without CCS were analyzed with SOD1 and COX4 antibodies or for dismutase activity (A, right).
(C) Cytosol and mitochondria purified from spinal cords of symptomatic SOD1G85R (line 148) and SOD1H46R/H48Q (line 139) transgenic mice were
assayed for accumulated SOD1 levels (top) and dismutase activity (bottom). MnSOD, manganese SOD activity.
CCS did not diminish this and reproducibly increased nontransgenic mice or mice expressing high levels of
hSOD1WT (Figure 4A, lanes 1–4).the proportion of mSOD1WT within the mitochondrial
fractions from both brain and spinal cord (Figures 3A Comparison of SDS-resistant, SOD1 immunoreactive
aggregates in SOD1G37R mice that do or do not expressand 3B, lane 4).
Analysis of cytosolic fractions from SOD1G85R or the CCS gene further revealed that, like toxicity, the very
slow mobility form and the lower band of the mitochon-SOD1H46R/H48Q confirmed that neither has detectable dis-
mutase activity (Figure 3C, lanes 1 and 3), consistent drial doublet were produced in the absence of CCS
(Figure 4B, lane 4, blue and filled dots, respectively).with previous reports (Bruijn et al., 1997; Wang et al.,
2002). Similarly, no dismutase activity corresponding to The more slowly migrating species of the doublet (open
dot) was completely absent in mice deleted of CCS.either SOD1 mutant was detectable in purified spinal
cord mitochondria. Therefore, detectable dismutase ac- Although this and its mobility suggested that this spe-
cies may represent a covalent adduct between SOD1G37Rtivity is not required for the high level of mutant SOD1
accumulation with spinal cord mitochondria (Figure 3C, (16 kDa) and CCS (32 kDa), immunoblotting with a CCS
antibody failed to confirm this (not shown).lanes 2 and 4).
Mutant SOD1s Result in Selective, Covalent Damage Age-Dependent Adducts of Mutant SOD1 Associated
with Mitochondria Is Selective to Spinal Cordto Mitochondrial Bound Proteins Independent
of Dismutase Activity and CCS Spinal cord mitochondria were also isolated from a
transgenic rat (Howland et al., 2002) that develops pro-Disease-causing mutant SOD1s have previously been
shown to generate prominent aggregates containing gressive ALS-like motor neuron disease due to expres-
sion of SOD1G93A. As in SOD1G93A mice (data not shown),both the mutant and wild-type SOD1s (Bruijn et al.,
1998), including the presence in spinal cord extracts a significant proportion of the SOD1G93A mutant is associ-
ated with spinal cord mitochondria purified from theseof SDS-resistant forms of much reduced mobility on
denaturing polyacrylamide gels (Johnston et al., 2000; rats beginning as early as 1.5 months of age (Figure 5A,
lane 6), 1–2 months prior to either disease onset or theWang et al., 2002). Both cytoplasmic and purified mito-
chondrial fractions from phenotypic SOD1 mutant mice development of aggregates of mutant SOD1 and/or the
protein folding chaperone Hsc70 (Howland et al., 2002).were examined for the presence of such aggregated
forms. In samples from four mouse models of ALS-like While no high molecular weight adducts of SOD1 were
present in nontransgenic or SOD1G93A rats at 1.5 monthsmotor neuron disease, immunoblotting with an SOD1
antibody revealed two slower mobility species at similar (Figure 5A, lanes 1–6), several slowly migrating species
were found exclusively associated with the mitochon-levels in the cytoplasmic compartment (Figure 4A, or-
ange dots). Similarly, the corresponding mitochondrial drial fraction (Figure 5A, lane 8) in 3.5-month-old, symp-
tomatic SOD1G93A rats. These slowly migrating speciesfractions, including those from mice expressing either
of the two dismutase-inactive mutants, contained a45 were comparable to those seen previously in the mouse
models (Figure 4). Therefore, enrichment of mutantkDa doublet (Figure 4A, open and filled dots) along with
a very slowly migrating SOD1 immunoreactive species SOD1 and apparent covalent adducts of it with spinal
cord mitochondria are common features of ALS-like dis-that just entered the resolving gel (Figure 4A, blue dots).
Each of these more slowly migrating species was mutant ease in rodents.
Mitochondria were also purified from the brainstem,SOD1 dependent, as none of these species was found
in either the cytoplasmic or mitochondrial fractions of cerebellum, cortex, and the remaining brain regions
Neuron
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Figure 4. Mutant SOD1s Accumulating with Spinal Cord Mitochondria Result in Age-Dependent Adducts of Mutant SOD1 with Other Proteins
Independent of Dismutase Activity and CCS
Cytosolic (cyto) and purified spinal mitochondrial (mito) fractions from a series of mouse lines (as indicated) were analyzed by immunoblotting
with an antibody that binds with equal affinity to both human and mouse SOD1. Beyond transgene encoded SOD1 and endogenous mouse
SOD1, a series of slower mobility SOD1 immunoreactive forms were detected including a very slowing migrating form (blue dots), two cytosolic
forms (orange dots), and two mitochondrial-specific forms (open and black dots), one of which (open dot) requires the presence of CCS.
Figure 5. Age-Dependent Association of Mutant SOD1 Adducts Exclusively with Spinal Cord Mitochondria
Cytosolic (cyto) and purified spinal mitochondrial (mito) fractions from nontransgenic and SOD1G93A transgenic rats were analyzed by immu-
noblotting with an antibody that binds with equal affinity to human and rat SOD1s. Spinal cord tissues (A) and different parts of the brain (B)
including brainstem, cerebellum, cortex, and the rest of the brain (others) were immunoblotted with an antibody with equal affinity for rat
SOD1 and SOD1G93A and an antibody to COX4 (top) or the same rat/human SOD1 antibody without antibody to COX4 (middle). The bottom
panel in (B) is a lower exposure of the middle panel. Green dots in (A) mark two slower mobility adducts in the purified spinal mitochondria
from symptomatic rats.
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are detected with a SOD1 antibody against the C-ter-
minal domain truncated in SOD1G127X (Figure 6, bottom).
SOD1G127X accumulation was most pronounced for spinal
cord mitochondria. Association of a lower level of mu-
tant SOD1G127X, including the absence of the slower mo-
bility adducts, was also seen in mitochondria from motor
or occipital cortex (Figure 6, lanes 6 and 8).
Association of Misfolded Mutant SOD1
with the Cytoplasmic Surface
of Spinal Cord Mitochondria
The nature of the association of disease-causing SOD1
mutants with spinal cord mitochondria was initially iden-
tified by accessibility of the SOD1G85R mutant to digestion
by an added protease. Although hSOD1WT, as well as
the active mutants SOD1G37R and SOD1G93A, are strongly
resistant to proteolysis in the presence or absence of
detergents (Ratovitski et al., 1999), the inactive, moreFigure 6. Selective Association of SOD1G127X in Affected Tissues of
poorly folded SOD1G85R is easily digested. Taking advan-a Familial ALS Patient
tage of this, mitochondria were freshly purified fromCytosol and mitochondria were purified from postmortem human
tissues from a sporadic ALS (SALS) patient and from a patient with a spinal cords of symptomatic SOD1G85R mice, and ali-
SOD1G127X mutation. Immunoblots were probed with COX4 antibody quots were treated with proteinase K in the absence
(top), an antibody that preferentially identifies the SOD1G127X mutant or presence of detergent to permeabilize mitochondrial
(middle) (see Experimental Procedures), and a SOD1 antibody to the membranes (Figures 7A and 7B). Consistent with intact
C-terminal domain of hSOD1 truncated in the SOD1G127X frameshift
outer membranes in the isolated mitochondria in the(bottom). White dots in lane 4 show positions of two SOD1G127X-
absence of added detergent, Tim23, a component ofcontaining species that migrate slower than the major SOD1G127X
the mitochondrial inner membrane, was resistant to pro-species.
teolysis (Figure 7B, lane 3) when detected with a Tim23
antibody recognizing an epitope within the IMS. At the
same level of added protease, all Tim23 was degraded(others) of the SOD1G93A rat. Despite similar levels of
after detergent-mediated membrane disruption (Figuremutant SOD1G93A associated with these mitochondria
7B, lane 4). Similarly, the integral inner membrane com-and those from spinal cord (compare Figure 5A, lane 8,
ponent, COX 4, was also resistant to proteinase K diges-with Figure 5B, lanes 10, 12, 14, 16), covalently modified
tion only in the absence of membrane lysis. (Cytochromeadducts of SOD1G93A were found exclusively associated
c, a releasable IMS protein, was resistant to the mildwith mitochondria from spinal cord. Since brain mito-
proteolysis conditions whether or not the outer mem-chondria-associated mutants do not result in covalent
brane was intact.) Both SOD1G85R and its slower mobilitymodification of SOD1G93A as they do in spinal cord (Figure
adducts that were found only in association with spinal5A, indicated by green dots), mutant-mediated damage
cord mitochondria (Figure 7B, lane 2) were quantitativelyto mitochondrial bound proteins is spinal cord specific.
degraded in the absence of detergent (Figure 7B, com-
pare lanes 2 and 3), consistent with binding of SOD1G85R
Preferential Association of Mutant SOD1 with Spinal onto the cytoplasmic face of mitochondria.
Cord Mitochondria in Human Familial ALS Location of mitochondrial SOD1 was tested further by
Spinal cord and brain mitochondria were isolated from immunogold electron microscopy using a human SOD1-
an autopsy sample from an ALS patient whose disease specific peptide antibody (Clement et al., 2003) and mi-
was caused by a frameshift mutation at codon 127 tochondria purified from symptomatic SOD1G85R mice.
(SOD1G127X). This frameshift mutant accumulates to a This revealed that 77% (64/83) of spinal cord mitochon-
level so low (1%–2% of that of the remaining wild- dria had detectable SOD1G85R associated with them. Sim-
type allele) that it is undetectable using typical SOD1 ilarly, despite little SOD1G85R associated with mitochon-
antibodies (Jonsson et al., 2004). To identify the mutant, dria purified from whole brain (Figure 2C), 66% (32/48)
an antibody was generated to a peptide including 17 of mitochondria from the cortex had bound mutant. Most
residues (CIIGRTLVVHEKADDLG) of hSOD1 and 5 addi- SOD1G85R was found at or near the cytoplasmic surface
tional amino acids (GQRWK) representing the new car- of spinal cord (Figures 7C, 7E, and 7F) or cortex (Figures
boxyl terminus of SOD1G127X that are encoded by the 7D and 7G–7I) mitochondria. Counting of gold particles
wrong SOD1 reading frame following the frameshift muta- associated with the periphery of the mitochondrial outer
tion. This antibody preferentially recognized SOD1G127X, al- membrane revealed a density of gold labeling four times
though as expected it also reacted with the much more that found in the central IMS space (Figure 7L). Analysis
abundant hSOD1WT (Figure 6, lane 3). Immunoblots with of mitochondria from cortex of a symptomatic SOD1G37R
this antibody revealed a striking (more than 10-fold) en- mouse (Figures 7J and 7K) revealed comparable propor-
richment of the SOD1G127X mutant in gradient-purified tions of this fully active mutant to be associated with
mitochondria from spinal cord extracts (Figure 6, lane 4), the periphery and the IMS (Figure 7L), consistent with
as well as accumulation of two additional, more slowly successful import of a significant fraction of this mutant
migrating mutant species (white dots). All of these repre- after initial association with mitochondrial components
on the cytoplasmic face.sent altered forms of SOD1G127X, not hSOD1WT, since none
Neuron
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Figure 7. Mutant SOD1 Is Aggregated onto the Cytoplasmic Side of Spinal Cord Mitochondrial Outer Membranes and Imported into the IMS
of Mitochondria
(A) Schematic of fractionations of spinal mitochondria in parts (B) and (M).
(B) Quantitative degradation of mitochondrially associated SOD1G85R and its slower mobility adducts after addition of proteinase K in the
absence of detergent. Proteinase K was added to 100 g/ml to the cytosol or purified mitochondria from SOD1G85R mice and the fractions
then analyzed by immunoblotting for remaining SOD1 (mSOD1WT and SOD1G85R), COX4, Tim23, Hsc70, or cytochrome c. Analyses were
performed in parallel with or without addition of Triton X-100, as indicated, to a final concentration of 0.2%.
(C–K) Immunogold electron microscopy following postembedment labeling of purified mitochondria from spinal cords (SC) or cortex (CTX) of
SOD1G85R (C–I) or SOD1G37R (J and K) mice using an antibody specific for human SOD1. Scale bars equal 300 nm.
(L) Densities of peripheral or internal gold particles from images such as (B)–(K). Background densities of gold particles for CTX and SC are
0.001 and 0.0005 particle/m2, respectively.
(M) Mitochondria purified from symptomatic SOD1G93A rats were treated with alkali as in (A), and supernatants (S1 and S2) and the final
membrane-associated pellet (P2) were immunoblotted for mutant and rSOD1WT (top), as well as the intermembrane component cytochrome
C (bottom) or the mitocondrial import component TOM20 (middle), an integral membrane protein.
Furthermore, treatment with alkali (which releases sol- While the alkali-soluble proportion of SOD1G93A was con-
sistent with a previous report of a significant level ofuble proteins and those bound peripherally to mem-
branes, but not integral membrane proteins [Fujiki et al., this mutant accumulated in the IMS (Higgins et al., 2002),
the majority of the SOD1G93A was very tightly membrane1982]) removed less than half of the SOD1G93A associated
with membranes of purified spinal cord mitochondria. associated, remaining membrane bound even after re-
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peated alkali treatment (Figures 7A and 7M, lane 4). chondrial import and how this pathway relates to the
mechanisms and components previously describedCytochrome c, which is tethered in the IMS, was quanti-
(Pfanner and Wiedemann, 2002).tatively released by alkali as expected (Figure 7M), while
We propose that the universal association of SOD1integral membrane proteins, such as Cox 4 or those of
mutant with mitochondria exclusively within affected tis-the mitochondrial import machinery (e.g., TOM 20; Fig-
sues represents the common property of these mutantsure 7M) were quantitatively retained in the alkali-resis-
that initiates a cascade of damage (Figure 8). In thistant, membrane-associated pellets.
view, the mutants initially damage mitochondria by ag-
gregation onto integral membrane components (includ-Discussion
ing those directly involved in import) and/or within the
IMS, impeding the normal functioning of those compo-One of the great puzzles in the study of inherited neuro-
nents in either compartment. Active mutants that binddegenerative diseases is why the nervous system, and
the catalytic copper either in the cytoplasm and/or IMSparticular subsets of neurons, is selectively targeted
may damage themselves by their own (aberrant) cataly-for toxicity by widely or ubiquitously expressed mutant
sis, thereby exacerbating kinetically or thermodynami-proteins. This study offers one of the first glimpses into
cally unstable protein folding. Inactive, inherently mis-how cells from the spinal cord may be selectively tar-
folded mutants like SOD1G85R are probably recipients ofgeted for degeneration in models of ALS: SOD1 mutants
damage after aggregation, perhaps as a consequencewith highly divergent biochemical characteristics and a
of proximity to reactive species released from or within20-fold disparity among cytoplasmic levels are recog-
mitochondria. Such damage further enhances mutantnized as import substrates by components on the cyto-
misfolding, perhaps driving mutant oligomerization asplasmic face of spinal cord mitochondria, with similar
has been seen in structural analyses of two such mu-amounts of each very tightly associated with mitochon-
tants (Elam et al., 2003) and/or formation of SDS-resis-drial import components and/or other integral mitochon-
tant adducts to other mitochondrial components. Suchdrial membrane proteins. Mutant association and import
a “feed forward” amplification mechanism could explaindoes not occur in unaffected tissues such as muscle or
the precipitous, rapid loss of motor neurons after dis-liver. This universal presence of mutant SOD1 on and
ease initiation.in spinal cord mitochondria begins contemporaneous
The tissue selectivity of mitochondrial associationwith the earliest pathology and well prior to disease
strongly implies that spinal cord-specific mitochondrialonset, is found for both catalytically active and inactive
and/or cytoplasmic factors are necessary to facilitatemutants, is unaffected by CCS-dependent loading of
association. The known mitochondrial import pathwaythe catalytic copper, and is most strikingly found in hu-
requires the cytoplasmic chaperones Hsp90/70 for de-man ALS caused by an unstable SOD1 mutant that accu-
livery of unfolded proteins (Young et al., 2003) andmulates only to trace cytoplasmic levels. Because a
strongly favors metal-free apo SOD1 proteins for deliv-high fraction of spinal mitochondria have mutant SOD1
ery of wild-type SOD1 into mitochondria (Okado-Matsu-associated, it is highly likely that many of these must
moto and Fridovich, 2002; Field et al., 2003). Indeed,
be generated in cell types beyond motor neurons, con-
toxicity can be delayed by co-induction of a stress re-
sistent with the non-cell-autonomous toxicity of these
sponse including Hsp70 and Hsp90 (Kiernan et al., 2004).
mutants (Clement et al., 2003). Collectively, these find-
Thus, one conserved aspect of toxicity may be impair-
ings support mitochondrial association to be directly ment of mitochondrial import pores with poorly folded,
related to disease toxicity. covalently crosslinked mutant SOD1 independent of ei-
Since essentially no wild-type SOD1 is found in spinal ther dismutase activity or a requirement for the catalytic
cord mitochondrial fractions, mutant association cannot copper. Selective mitochondrial damage is consistent
simply reflect a general pathway of mitochondrial import with other examples of neurodegenerative disease, in-
of SOD1, residual cytoplasmic contamination of the puri- cluding mutations in Hsp60, a mitochondrial matrix pro-
fied mitochondria, or leaky, mutant-damaged outer mi- tein, and frataxin, an inner membrane protein, which
tochondrial membranes. The absence of wild-type result in hereditary spastic paraplegia and Friedreich
SOD1 from spinal cord mitochondria coupled with a high ataxia, respectively (Koehler et al., 1999; Roesch et al.,
proportion of dismutase active mutant SOD1s appar- 2002; Puccio and Koenig, 2002; Hansen et al., 2002;
ently imported into the IMS, while inactive mutants are Ho¨rtnagel et al., 2003). Moreover, mutation in a compo-
primarily aggregated onto the cytoplasmic surface, nent of mitochondrial import, TIMM8a, causes human
firmly indicates that misfolded mutant SOD1s are recog- deafness dystonia (Roesch et al., 2002).
nized by spinal mitochondria as substrates for selective Finally, selective SOD1 mutant-mediated damage to
import. Conversely, the appearance of a significant pro- spinal cord mitochondria as a primary toxicity in ALS is
portion of wild-type SOD1, but not SOD1 mutants, in especially attractive since mitochondria are the gate-
purified mitochondria from liver clearly reveals the pres- keepers of caspase-directed cell death (Newmeyer and
ence of one or more heretofore unrecognized, cell type- Ferguson-Miller, 2003). Indeed, death of motor neurons,
specific mechanisms for such association and pre- but not other neurons, from activation of an intrinsic
sumed import. The involvement in ALS of factors that cell death pathway involving both motor neuron-specific
mediate tissue-specific mitochondrial import also offers and a classic mitochondrially mediated FADD/caspase
a simple explanation for the association with ALS of a 8 pathway can be enhanced by SOD1 mutants (Raoul
variant in the import signal of the mitochondrial SOD2 et al., 2002). Accumulation of mutant SOD1 has also
(Van Landeghem et al., 1999). Further work is now critical been associated with cytochrome c release from mito-
chondria, translocation of Bax, truncation of Bid, andto identify the tissue-specific factors that modify mito-
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Figure 8. Model for Selective ALS-Linked
SOD1 Mutant-Mediated Damage Selectively
to Spinal Mitochondria by Impairing Import
Channels
(A) In the normal spinal cord cells, little
SOD1WT is either associated with spinal mito-
chondria or imported into the IMS despite
uptake into mitochondria from liver (Figure
2C; Okado-Matsumoto and Fridovich, 2001).
(B) As we have shown here, ALS-linked SOD1
mutants all selectively associate with spinal
mitochondria, with a proportion of each ag-
gregated on the cytoplasmic surface. An ad-
ditional proportion is imported, presumably
requiring the action of both the Hsp70 and
Hsp90 chaperones for unfolding and presen-
tation to the TOM import complex, as has
been shown for other import substrates (Kier-
nan et al., 2004). The selectivity of association
with spinal mitochondria suggests action of
as yet unidentified cytoplasmic and/or mito-
chondrial factors that are unique to spinal
cord and that facilitate association. Associa-
tion is probably driven by mutant misfolding,
accompanied by production of higher molec-
ular weight adducts and SDS-resistant ag-
gregates. These clog import channels or otherwise inhibit outer mitochondrial membrane components, thus functionally damaging mitochondria.
Mutants that bind the catalytic copper may also catalyze aberrant chemistry on one or both sides of the mitochondrial outer membrane.
Subcellular Fractionationactivation of the executioner caspase 3 (Vukosavic et
Mitochondria were purified by a modification of an earlier protocolal., 2000; Pasinelli et al., 2000; Li et al., 2000; Guegan et
(Okado-Matsumoto and Fridovich, 2001). Tissues (frozen or fresh)al., 2001, 2002). Survival can be extended by increased
were homogenized at 1:5 (w/v) ratio (in a buffer containing 210 mM
synthesis of the apoptosis inhibitor Bcl-2 (Kostic et al., mannitol, 70 mM sucrose, 10 mM Tris [pH 7.5], and 1 mM EDTA [pH
1997), infusion of a broad-spectrum caspase inhibitor 7.5]) and centrifuged at 1300  g for 10 min. The pellet was washed
with a half volume of the same buffer and the supernatants were(Li et al., 2000), or by administration of minocycline,
combined and centrifuged again. The subsequent supernatant waswhich has been correlated with inhibition of cytochrome
then centrifuged at 17,000 g for 15 min to produce a crude mitochon-c release from mitochondria (Zhu et al., 2002). When
drial pellet. The supernatant was further subjected to centrifugationcombined with multiple lines of evidence that have dem-
at 100,000  g for 1 hr and the final supernatant was designated
onstrated that toxicity is non-cell-autonomous, that is, the cytosolic fraction. The crude mitochondrial pellet was washed
does not arise solely from mutant damage directly within once with 50 mM KCl (in the extraction buffer) and sedimented at
52,000 g for 1.5 hr on a discontinuous Nycodenz gradient (Okado-motor neurons (Lino et al., 2002; Gong et al., 2000; Pra-
Matsumoto and Fridovich, 2001). Material at the 25%–30% interfacematarova et al., 2001; Clement et al., 2003), the presence
was collected and designated as purified mitochondria. Protein con-in one or more spinal cord cell types of components
centrations were measured using the BCA method. In the case ofthat mediate mitochondrial association and import of
Thy1-SOD1G85R mice, frozen spinal cords were combined with SOD1
SOD1 mutants provides a mechanistic explanation for null cortex materials (1:3, w/w) before subcellular fractionation so
selective toxicity to motor neurons from ubiquitously as to have enough overall starting tissue extract to purify mitochon-
dria. To remove soluble IMS components and peripheral membraneexpressed SOD1 mutants in familial ALS.
proteins, purified spinal cord mitochondria were resuspended in
alkali (0.1 M Na2CO3 [pH 11.5]), incubated on ice for 30 min, andExperimental Procedures
then centrifuged at 100,000  g for 30 min, as previously described
(Fujiki et al., 1982).Transgenic Mice
Transgenic mice expressing hSOD1WT, SOD1G37R, and SOD1G85R were
as originally described (Wong et al., 1995; Bruijn et al., 1997).
Immunoblot AnalysisSOD1G93A transgenic mice (Gurney et al., 1994) expressing lower and
Samples were separated on either regular SDS-PAGE gel or SDS-higher levels were obtained from the Jackson Laboratory. Trans-
PAGE containing 3 M urea and transferred to nitrocellulose andgenic mice expressing SOD1H46R/H48Q were from Wang et al. (2002);
probed with various antibodies including a rabbit polyclonal raisedtissues from transgenic mice expressing SOD1G85R under the Thy1
against a peptide identical in human, rat, and mouse SOD1s and apromoter (Lino et al., 2002) were provided by Dr. Pico Caroni. Trans-
peptide antibody recognizing human, but not mouse or rat, SOD1genic rats expressing SOD1G93A were described by Howland et al.
(Clement et al., 2003; Howland et al., 2002). A polyclonal antibody(2002).
to SOD1G127X mutant was generated to the 22 carboxy-terminal amino
acids (CIIGRTLVVHEKADDLGGQRWK) as described (Jonsson et al.,Human Autopsy Samples
2003). This was affinity purified against the peptide and pre-All ALS autopsy samples were obtained with informed consent and
adsorbed with hSOD1WT that had been denatured by exposure tofrozen at80C. Sporadic ALS samples were obtained from a collec-
6 M guanidinium chloride and 3 mM of the copper chelator DTPA.tion at Johns Hopkins University School of Medicine. In confor-
COX4 and cytochrome c antibodies were from CloneTech. Hsp60,mance with the Helsinki Declaration approval by the ethical commit-
syntaxin 6, and synaptotagmin antibodies were from StressGen.tees of the Universities of Copenhagen and Umea˚, samples from
HRP-conjugated anti-mouse or anti-rabbit IgG secondary antibod-a patient carrying the SOD1G127X mutation were obtained after a
postmortem time of 20 hr. ies were used and detected by ECL (Amersham).
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Immuno-Electron Microscopy Borchelt, D.R., Lee, M.K., Slunt, H.S., Guarnieri, M., Xu, Z.S., Wong,
P.C., Brown, R.H., Jr., Price, D.L., Sisodia, S.S., and Cleveland, D.W.Mitochondria were isolated from fresh tissues, collected in homoge-
nization buffer, and fixed by addition of an equal volume of fixative (1994). Superoxide dismutase 1 with mutations linked to familial
amyotrophic lateral sclerosis possesses significant activity. Proc.(4% formaldehyde, 0.4% glutaraldehyde, 4 mM CaCl2 in 0.1 M caco-
dylate buffer [pH 7.3]) and incubation for 30 min at 4C. Mitochondrial Natl. Acad. Sci. USA 91, 8292–8296.
pellets were then collected and washed with 0.1 M cacodylate/2 mM Bruijn, L.I., Becher, M.W., Lee, M.K., Anderson, K.L., Jenkins, N.A.,
CaCl2 and processed for embedment in LR White (EMS). Ultrathin Copeland, N.G., Sisodia, S.S., Rothstein, J.D., Borchelt, D.R., Price,
sections (70–80 nm) were collected on 300 mesh nickel grids. Sec- D.L., and Cleveland, D.W. (1997). ALS-linked SOD1 mutant G85R
tions were etched with saturated sodium periodate (Sigma, St. Louis, mediates damage to astrocytes and promotes rapidly progressive
MO) for 15 min and blocked with 4% bovine albumin (BSA) in Tris- disease with SOD1-containing inclusions. Neuron 18, 327–338.
buffered saline (TBS) for 45 min. Grids were incubated with a human Bruijn, L.I., Houseweart, M.K., Kato, S., Anderson, K.L., Anderson,
SOD1-specific peptide antibody (1:100) in 1% BSA/TBS and incu- S.D., Ohama, E., Reaume, A.G., Scott, R.W., and Cleveland, D.W.
bated at 4C overnight followed by goat anti-rabbit IgG conjugated (1998). Aggregation and motor neuron toxicity of an ALS-linked
to 10 nm gold (Amersham, Arlington Heights, IL, 1:30) for 1 hr at room SOD1 mutant independent from wild-type SOD1. Science 281, 1851–
temperature. The sections were postfixed in 2% glutaraldehyde for 1854.
20 min, rinsed in distilled water, and contrasted with 2% uranyl
Clement, A.M., Nguyen, M.D., Roberts, E.A., Garcia, M.L., Boillee,acetate for 15 min and lead citrate for 10 min. Sections were ob-
S., Rule, M., McMahon, A.P., Doucette, W., Siwek, D., Ferrante, R.J.,served in a Philips (model 208) electron microscope. Gold particles
et al. (2003). Wild-type nonneuronal cells extend survival of SOD1in the central and peripheral mitochondrial areas were counted. The
mutant motor neurons in ALS mice. Science 302, 113–117.peripheral region was defined as that within 30 nm of either side
Cleveland, D.W., and Rothstein, J.D. (2001). From Charcot to Louof the outer mitochondrial membrane, a distance representing the
Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev.theoretical maximum distance a gold particle could be from the
Neurosci. 2, 806–819.antigen, based on the approximate length of the two 15 nm long
IgG molecules separating the gold and the antigen. Corson, L.B., Strain, J.J., Culotta, V.C., and Cleveland, D.W. (1998).
Chaperone-facilitated copper binding is a property common to sev-
Dismutase Activity Assay eral classes of familial amyotrophic lateral sclerosis-linked superox-
Superoxide dismutase assays were performed in situ (Borchelt et ide dismutase mutants. Proc. Natl. Acad. Sci. USA 95, 6361–6366.
al., 1994) after separation on 7.5% nondenaturing acrylamide gels Culotta, V.C., Klomp, L.W., Strain, J., Casareno, R.L., Krems, B., and
containing 25% glycerol. Gels were stained in 50 mM potassium Gitlin, J.D. (1997). The copper chaperone for superoxide dismutase.
phosphate buffer (pH 7.8) containing 82 M riboflavin, 0.1 mM nitro- J. Biol. Chem. 272, 23469–23472.
bluetetrozolium, and 27.5 M TEMED for 45 min on a shaker, and
Dal Canto, M.C., and Gurney, M.E. (1994). Development of centralthen briefly destained.
nervous system pathology in a murine transgenic model of human
amyotrophic lateral sclerosis. Am. J. Pathol. 145, 1271–1279.Acknowledgments
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